- Home
- CATX vs INNV Comparison
CATX vs INNV Comparison
Compare CATX & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATX | INNV |
|---|---|---|
| Founded | 1983 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.6M | 1.2B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CATX | INNV |
|---|---|---|
| Price | $4.17 | $7.80 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 9 | 1 |
| Target Price | ★ $12.11 | $7.00 |
| AVG Volume (30 Days) | ★ 1.4M | 329.5K |
| Earning Date | 03-16-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $853,699,000.00 |
| Revenue This Year | $12.71 | $12.85 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $58.07 |
| Revenue Growth | N/A | ★ 11.76 |
| 52 Week Low | $1.60 | $2.60 |
| 52 Week High | $6.16 | $10.69 |
Technical Indicators
Market Signals| Indicator | CATX | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 44.27 |
| Support Level | $3.24 | $4.89 |
| Resistance Level | $4.54 | $9.18 |
| Average True Range (ATR) | 0.38 | 0.41 |
| MACD | -0.14 | -0.17 |
| Stochastic Oscillator | 9.44 | 8.09 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.